About Ameritox
Ameritox is a company based in Baltimore (United States) founded in 1996 was acquired by Aegis Science in March 2018. Ameritox has completed 1 acquisition, including PRIUM. Ameritox offers products and services including CBD Oil Guides, Drug Testing Articles, and Cannabis Strain Reviews. Ameritox operates in a competitive market with competitors including AccuRx, MedAware, IntegenX, Precision Diagnostics and Pyrls, among others.
- Headquarter Baltimore, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$175 M (USD), Debt – Venture
Jan 08, 2015
-
Investors
Aegis Science
& 6 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Aegis Science
(Mar 05, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ameritox
Ameritox offers a comprehensive portfolio of products and services, including CBD Oil Guides, Drug Testing Articles, and Cannabis Strain Reviews.
Resources on selecting and using CBD oil for health benefits.
Articles explaining drug test processes and marijuana detection methods.
Guides reviewing various cannabis strains and their effects.
Funding Insights of Ameritox
Investors in Ameritox
Ameritox has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Aegis Science, NewStar Financial and Fifth Street Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funds are managed for credit investing strategies.
|
Locked | Locked | Locked | |
|
Private equity firm
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked |
Investor details for Ameritox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ameritox
Ameritox has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PRIUM.
Investment portfolio details for Ameritox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Chronic pain intervention programs are provided to patients by PRIUM.
|
Locked | Locked | 1987 | Locked |
Complete acquisition details for Ameritox
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ameritox
Detailed financials for Ameritox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ameritox Comparisons
Peer comparison for Ameritox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ameritox
Ameritox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AccuRx, MedAware, IntegenX, Precision Diagnostics and Pyrls, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform to increase antibiotic prescribing accuracy in primary care
|
|
| Locked | Locked | Locked |
Provider of an AI based medication dosage and safety managing software for healthcare professionals
|
|
| Locked | Locked | Locked |
Instruments for rapid human DNA identification are developed.
|
|
| Locked | Locked | Locked |
Quantitative urine drug testing is provided for patient monitoring.
|
|
| Locked | Locked | Locked |
Cloud-based practical drug information platform for providers
|
|
| Locked | Locked | Locked |
Clinical decision support software for drug interactions is developed.
|
Detailed competitors of Ameritox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ameritox
Complete news archive for Ameritox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ameritox
Ameritox was founded in 1996 and raised its 1st funding round 11 years after it was founded.
Ameritox is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
A. Scott Walton is the current CEO of Ameritox.
Ameritox (Formerly known as Universal Toxicology Laboratories) develops pain medication monitoring solutions for behavioral health clinicians in the United States necessary to address the national epidemic of prescription drug misuse, abuse and diversion. It offers laboratory services and practice management tools; Rx GuardianCD, a urine drug monitoring solution that helps clinicians to identify potential abuse, misuse, or diversion of patient medication; Rx Guardian INSIGHT Report, which provides physicians with a view of their chronic pain patients medication monitoring results; and Rx Guardian results report that provides information available on patients pain medication use in easy-to-read format. The company also provides clinical staff training and support, results interpretation and support, contract and payer partnerships, billing and reimbursement, and practice management resources.
Ameritox's top competitors include AccuRx, IntegenX and Precision Diagnostics.
Ameritox offers CBD Oil Guides, Drug Testing Articles, and Cannabis Strain Reviews.
Ameritox has made 1 acquisition, including PRIUM.
Ameritox has 7 investors. Key investors include Aegis Science, NewStar Financial, Fifth Street Asset Management, Sterling Partners, and Sequoia Capital.